Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2003
11/13/2003US20030212068 Antiinflammatory agents; antiallergens; antiarthritic agents
11/13/2003US20030212066 1-Sulfonyl pyrrolidine derivatives
11/13/2003US20030212064 Triazolotriazinones and the use thereof
11/13/2003US20030212062 Morpholinone and morpholine derivatives and uses thereof
11/13/2003US20030212059 Adenosine A2a receptor antagonists
11/13/2003US20030212055 Cinnoline compounds
11/13/2003US20030212012 Prevention labor contraction; urogenital disorders
11/13/2003US20030211993 Control cell proliferation, cell differentiation; culture product
11/13/2003US20030211990 Central nervous system disorders; test kits
11/13/2003US20030211986 Protein a compositions and methods of use
11/13/2003US20030211969 Administering activated protein c; controlling blood coagulation
11/13/2003US20030211577 Novel G protein-coupled receptor, GAVE7
11/13/2003US20030211529 Human Eag2
11/13/2003US20030211513 Intracellular signaling proteins
11/13/2003US20030211493 Comprises membrane protein for diagnosis, prevention and treatment of infections, cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory and metabolic disorders
11/13/2003US20030211165 Anticancer agents; mixture of hydrophilic, crosslinked polymer and drugs
11/13/2003US20030211101 Vascular endothelial growth factor-like protein from ORF viruses binds and activates mammalian VEGF receptor-2, and uses thereof
11/13/2003US20030211040 Phosphodiesterase activity and regulation of phosphodiesterase 1B-mediated signaling in brain
11/13/2003CA2703698A1 Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent
11/13/2003CA2487693A1 Method for producing preparations rich in tocotrienol
11/13/2003CA2485116A1 Use of epa and dha in secondary prevention
11/13/2003CA2485098A1 Use of heat shock proteins to enhance efficacy of antibody therapeutics
11/13/2003CA2485093A1 Substituted imidazole derivatives: gabaa receptor ligands
11/13/2003CA2485086A1 A combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes
11/13/2003CA2485070A1 A process for the preparation of clopidogrel
11/13/2003CA2485065A1 Semicarbazide derivatives for combating thromboembolic diseases
11/13/2003CA2484959A1 Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same
11/13/2003CA2484874A1 Monocompartment osmotic controlled drug delivery system
11/13/2003CA2484797A1 Methods of treatment of glaucoma and other conditions mediated by nos-2 expression via inhibition of the egfr pathway
11/13/2003CA2484624A1 Carvedilol pharmasolve solvate
11/13/2003CA2484621A1 Carvedilol formulations
11/13/2003CA2484599A1 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
11/13/2003CA2484597A1 Thiazolidinones and the use thereof as polo-like kinase inhibitors
11/13/2003CA2484582A1 Bombesin antagonists
11/13/2003CA2484551A1 Smart pro-drugs of serine protease inhibitors
11/13/2003CA2484312A1 Catechin multimers as therapeutic drug delivery agents
11/13/2003CA2484258A1 Soya cell strains with high isoflavone content
11/13/2003CA2484209A1 Protein kinase modulators and methods of use
11/13/2003CA2484189A1 Methionine aminopeptidase-2 inhibitors and methods of use thereof
11/13/2003CA2484173A1 4-azasteroid derivatives as androgen receptor modulators
11/13/2003CA2484065A1 Inhibitors of histone deacetylase
11/13/2003CA2483996A1 Promoters exhibiting endothelial cell specificity and methods of using same
11/13/2003CA2483929A1 A method for inhibiting platelet aggregation
11/13/2003CA2483909A1 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
11/13/2003CA2483846A1 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
11/13/2003CA2483806A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders
11/13/2003CA2483787A1 Melanocortin receptor ligands
11/13/2003CA2483275A1 Method of treating vascular endothelial growth factor mediated vascular disorders using amfenac or nepafenac
11/13/2003CA2483001A1 A combination product comprising melagatran and an anti-arrhythmic oxabispidenes
11/13/2003CA2462645A1 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/12/2003EP1361225A1 Compounds substituted with bicyclic amino groups
11/12/2003EP1360967A1 Coated medical devices
11/12/2003EP1360965A1 Methods of treating diseases in association with decrease in the expression of aop-1 gene or aop-1 and remedies for the diseases
11/12/2003EP1360960A1 Use of ketoconazole and related substances in medicaments for treatment of type II diabetes
11/12/2003EP1360959A1 Use of 8-prenylflavanones for anti-angiogenesis therapy and for fibrinolytic therapy
11/12/2003EP1360508A2 Prediction of wound healing by urinary nitrate assay
11/12/2003EP1360486A2 Screening method for identifying compounds that selectively induce interferon alpha
11/12/2003EP1360319A2 Diagnosis of diseases associated with metabolism
11/12/2003EP1360307A2 Chimeric polypeptides of serum albumin and uses related thereto
11/12/2003EP1360295A2 Molecules for desease detection and treatment
11/12/2003EP1360205A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use
11/12/2003EP1360187A1 3,7-diazabicyclo(3.3.0)octanes and their use in the treatment of cardiac arrhythmias
11/12/2003EP1360186A2 Carboline derivatives
11/12/2003EP1360185A2 Carboline derivatives
11/12/2003EP1360184A1 Piperidinee derivatives as neurokinin 1 antagonists
11/12/2003EP1360182A1 4-aminobenzopyran derivatives
11/12/2003EP1360178A2 Novel heterocyclic analogs of diphenylethylene compounds
11/12/2003EP1360175A1 1g(a)-amino-n-hydroxy-acetamide derivatives
11/12/2003EP1360174A1 Phenethanolamine derivatives for treatment of respiratory diseases
11/12/2003EP1360173A2 Trisubstituted carbocyclic cyclophilin binding compounds and their use
11/12/2003EP1360172A1 Ppar agonists
11/12/2003EP1360170A1 Carboxylic amides, the production and use thereof as medicaments
11/12/2003EP1360167A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use
11/12/2003EP1359975A1 Ocular iontophoretic device and method of use
11/12/2003EP1359940A2 Combinations of statins, estrogenic agents and optionally estrogens
11/12/2003EP1359923A1 Use of selenite or preparations containing selenite for treating wounds
11/12/2003EP1359922A1 Novel receptors for $i(helicobacter pylori) and use thereof
11/12/2003EP1359920A2 Methods and formulations for the treatment of female sexual dysfunction
11/12/2003EP1359916A1 Imidazolyl derivatives as corticotropin releasing factor inhibitors
11/12/2003EP1359915A1 Urotensin-ii receptor antagonists
11/12/2003EP1359913A1 Thrombin inhibitors
11/12/2003EP1359907A2 Combination comprising an insulin secretion enhancer and an active ingredient selected from hmg-co-a reductase inhibitors and ace inhibitors
11/12/2003EP1359906A2 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids
11/12/2003EP1359904A2 P27 prevents cellular migration
11/12/2003EP1359900A1 A stable pharmaceutical formulation comprising torsemide modification ii
11/12/2003EP1359883A2 (psi)(epsilon)rack peptide composition and method for protection against tissue damage due to ischemia
11/12/2003EP1282614B1 Hydroxamic acid derivatives
11/12/2003EP1240164B1 Benzazole derivatives and their use as jnk modulators
11/12/2003EP1235809B1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments
11/12/2003EP1233973B1 Partial or full a1 agonists - n6 heterocyclic 5'-thio substituted adenosine derivatives
11/12/2003EP1206444B1 Compounds that inhibit tryptase activity
11/12/2003EP1181286B1 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides
11/12/2003EP1140139B1 Use of erythropoietin or erythropoietin derivatives for the treatment of cerebral ischaemia
11/12/2003EP1133308B1 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases
11/12/2003EP1115707B1 Benzamide derivatives and ther use as cytokine inhibitors
11/12/2003EP1112083B1 Use of an angiogenic factor for the treatment of microvascular angiopathies
11/12/2003EP1058549A4 THROMBIN OR FACTOR Xa INHIBITORS
11/12/2003EP1019373B1 1-acyl-3-phenyl-3-(3-piperidinopropyl)piperidine derivatives as human nk3 receptor selective antagonists
11/12/2003EP1011706B1 USE OF SOLUBLE RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS (sRAGE) TO PREVENT ACCELERATED ATHEROSCLEROSIS
11/12/2003EP1011696B1 Treatment of stress and preconditioning against stress
1 ... 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 ... 1595